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Park HC, Yasuda K, Ratliff B, Stoessel A, Sharkovska Y,
Yamamoto I, Jasmin JF, Bachmann S, Lisanti MP, Chander P,
Goligorsky MS. Postobstructive regeneration of kidney is derailed when
surge in renal stem cells during course of unilateral ureteral obstruction is
halted. Am J Physiol Renal Physiol 298: F357–F364, 2010. First pub-
lished November 11, 2009; doi:10.1152/ajprenal.00542.2009.—Unilat-
eral ureteral obstruction (UUO), a model of tubulointerstitial scarring
(TIS), has a propensity toward regeneration of renal parenchyma after
release of obstruction (RUUO). No information exists on the contri-
bution of stem cells to this process. We performed UUO in FVB/N
mice, reversed it after 10 days, and examined kidneys 3 wk after
RUUO. UUO resulted in attenuation of renal parenchyma. FACS
analysis of endothelial progenitor (EPC), mesenchymal stem (MSC)
and hematopoietic stem (HSC) cells obtained from UUO kidneys by
collagenase-dispersed single-cell suspension showed significant in-
crease in EPC, MSC, and HSC compared with control. After RUUO
cortical parenchyma was nearly restored, and TIS score improved by
3 wk. This reversal process was associated with return of stem cells
toward baseline level. When animals were chronically treated with
nitric oxide synthase (NOS) inhibitor at a dose that did not induce
hypertension but resulted in endothelial dysfunction, TIS scores were
not different from control UUO, but EPC number in the kidney
decreased significantly; however, parenchymal regeneration in these
mice was similar to control. Blockade of CXCR4-mediated engraft-
ment resulted in dramatic worsening of UUO and RUUO. Similar
results were obtained in caveolin-1-deficient but not -overexpressing
mice, reflecting the fact that activation of CXCR4 occurs in caveolae.
The present data show increase in EPC, HSC, and MSC population
during UUO and a tendency for these cells to decrease to control level
during RUUO. These processes are minimally affected by chronic
NOS inhibition. Blockade of CXCR4-stromal cell-derived factor-1
(SDF-1) interaction by AMD3100 or caveolin-1 deficiency signifi-
cantly reduced the UUO-associated surge in stem cells and prevented
parenchymal regeneration after RUUO. We conclude that the surge in
stem cell accumulation during UUO is a prerequisite for regeneration
of renal parenchyma.
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GLOMERULOSCLEROSIS and tubulointerstitial scarring (TIS)—the
main processes governing progression of chronic renal diseases—
are well studied and described (3, 7–9, 11, 15). Unilateral ureteral
obstruction (UUO) has been consistently utilized as a conve-
nient model of TIS, although this process is much less pro-
nounced in mice than in rats, rabbits, and dogs (5). This model
has provided valuable insights into the molecular and cellular
mechanisms of TIS progression. Specifically, the role of vari-
ous subsets of infiltrating leukocytes, hypoxia, angiotensin II,
transforming growth factor (TGF)-, TNF-, plasminogen
activator inhibitor-1, and reactive oxygen species, to name a
few, has been established (reviewed in Refs. 3, 5, 7–9, 11, 15).
Notwithstanding these advances, significant controversies ex-
ist. For instance, the role of stem cells in progression of fibrosis
has not been unequivocally established. In a UUO model,
Roufosse et al. (17) showed no contribution of bone marrow-
derived cells to progression of fibrosis. On the other hand,
Yamashita et al. (26) provided evidence that renal resident
label-retaining cells undergo transition to myofibroblastic phe-
notype, thus potentially contributing to the progression of
fibrosis. Most recent studies from Weinberg’s laboratory (12)
have challenged this dogma by demonstrating the ability of
epithelial cells that have undergone epithelial-mesenchymal
transition to generate stemlike cells. Hence, in general and in
this particular case of UUO, the role of stem cells in the
progression of TIS remains unresolved.
In this vein, an impressive ability of obstructed shrunken
kidneys to structurally regenerate renal parenchyma may be
instructive. Clinical experience suggests that the release of
UUO (RUUO) not only does not lead to progressive deterio-
ration but is rather associated with improved renal function (2,
16). In experimental RUUO, Cochrane et al. (6) demonstrated
partial functional recovery, reduced macrophage infiltration,
and decreased proline and collagen content compared with the
obstructed state. Could this model provide insights into the role
of stem cells during the obstruction, but most importantly,
during the postobstructive remodeling of the kidney? Could
other factors recently implicated in tipping the balance between
fibrosis and regenerative processes, such as the presence of
endothelial dysfunction and expression of caveolin-1, modu-
late the outcome? These questions were addressed in the
present study, the results of which demonstrate that preventing
the accumulation of hematopoietic stem cells (HSC) and mes-
enchymal stem cells (MSC) during UUO disrupts post-RUUO
regeneration of the renal parenchyma.
MATERIALS AND METHODS
Animal studies. Adult male FVB/N mice (10–12 wk old) were
obtained from the Jackson Laboratory (Bar Harbor, ME). Caveolin-
1/ and caveolin-1-overexpressing transgenic male mice of the
same age were generated by M. P. Lisanti’s laboratory. The animal
study protocol was in accordance with the National Institutes of
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Health (NIH) Guide for the Care and Use of Laboratory Animals and
was approved by the Institutional Animal Care and Use Committee.
Initially, nine groups of animals were studied (Table 1). Animals in
groups 2, 3, 5, 6, 8, and 9 were subjected to left UUO for 10 days.
Briefly, animals were anesthetized and placed on a heated surgical
pad. The left ureter was visualized via a flank incision and ligated with
a vascular clamp (0.4–1.0 mm; Fine Science Tools, Foster City, CA).
The UUO was released after 10 days of UUO in groups 3, 6, and 9,
and the kidneys were allowed to recover for 3 wk before death. The
right unobstructed kidney served as the control. The animals in groups
4–6 received NG-monomethyl-L-arginine (L-NMMA, Axxora, San
Diego, CA; 0.3 mg/ml) in drinking water throughout the study period.
The animals in groups 7–9 received AMD3100, a competitive antag-
onist of CXCR4 (Sigma-Aldrich, St. Louis, MO; 5 mg/kg ip) during
the initial 10 days of obstruction, according to the previously pub-
lished protocol (4). In a separate group of experiments, caveolin-
1/ and caveolin-1-overexpressing transgenic male mice under-
went UUO for 10 days.
Assessment of renal morphology and interstitial fibrosis. Kidneys
were collected from mice after 10 days of UUO or 3 wk after RUUO
for structural analysis (n  4–6 for each group). At harvest, each
kidney was washed with saline, blotted dry on gauze, and weighed.
Whole kidney weight was expressed as a percentage of body weight
determined at the time when mice were euthanized. Midcoronal
kidney sections were fixed in 4% paraformaldehyde (PFA) and
embedded in paraffin. Paraffin sections (4 m thick) were stained with
hematoxylin and eosin (H & E), periodic acid Schiff, and Masson’s
trichrome and examined by pathologists blinded to the experimental
design. A semiquantitative scale, designed to evaluate the degree of
tubulointerstitial injury including tubular atrophy and dilatation (cor-
tex and medulla) and fibrosis (cortex, medulla, papilla, and perivas-
cular area) was used. The tubulointerstitial injury and fibrosis score
ranging from 0 to 3 was determined as follows: 0, normal kidney; 1,
mild change; 2, moderate change; 3, severe change. Alternatively,
kidney sections were stained with Sirius red and scored on the basis
of pixel intensity. Changes in renal pelvis and papillary area were also
assessed by scores ranging from 0 to 3 with similar criteria. The scores
were determined in each section selected at random, and 20 fields
were examined under 100 magnification. The composite tubuloin-
terstitial injury score (TIS) was derived from addition of tubular injury
and fibrosis scores. Estimation of cortical thickness was done by
measuring the distance from renal capsule to corticomedullary junc-
tion.
Isolation of renal cells from whole kidney. For preparation of cell
suspensions, individual kidneys from each experimental group were
placed in 2 ml of ice-cold RPMI 1640 (Invitrogen, Carlsbad, CA) and
minced into small pieces of 1 mm with a sterile scalpel. Digestion
of the tissue was performed in collagenase II (Invitrogen) solution (1
mg in 1 ml of RPMI 1640) for 30 min at 37°C in a 5% CO2 incubator.
Cell suspensions were passed through a 35-m nylon sieve. Repeated
digestions were performed until microscopic evaluation showed a
suspension of single cells. Finally, cells were washed in PBS-BSA 1%
(wt/vol), counted in a Neubauer chamber, and kept on ice in the dark
until further analysis. The cell preparation contained intrinsic renal
cells and infiltrating cells.
FACS analysis. To quantify the population of endothelial progenitor
cells (EPC), HSC, and MSC, 1 106 cells from the respective single-cell
suspensions were incubated with different primary antibodies for 1 h at
4°C in the dark. The following antibodies were used: FITC-conjugated
anti-mouse CD34 (RAM34; eBioscience, San Diego, CA), phycoerythrin
(PE)-conjugated anti-mouse Flk-1 (Avas12a1; BD Biosciences, Rock-
ville, MD), PE-conjugated anti-mouse CD150 (eBioscience), FITC-
conjugated anti-mouse CD117 (c-Kit; BD Biosciences), monoclonal
anti-rat Nestin (Rat-401, Developmental Studies Hybridoma Bank,
University of Iowa), and monoclonal anti-vimentin (clone LN-6,
Sigma). The cells were permeabilized with 0.2% Triton X-100 for
nestin and vimentin staining, and after incubation with nestin and
vimentin antibodies cells were incubated with FITC- or Texas red-
conjugated goat secondary antibodies (Jackson Immunoresearch,
West Grove, PA). In addition, staining was also performed with
fluorophore-conjugated antibodies against CD44 and CD29 (both
from BD Biosciences). After each incubation step, cells were washed
with PBS-BSA 1% (wt/vol) and finally fixed in 1% PFA. Data were
acquired with a FACScan cytometer equipped with a 488-nm argon
laser and a 635-nm red diode laser and analyzed with CellQuest
software (Becton Dickinson). The setup of the FACScan was per-
formed with unstained and secondary antibody-stained cells. For
quantification of EPC and HSC, the number of CD34/Flk-1 and
CD150/c-Kit double-positive cells, respectively, within the monocytic
cell population was counted. MSC were quantified by counting cells
positive for nestin, vimentin, or CD44 and CD29.
Statistical analyses. Values are expressed as means 	 SE. For
comparison between two groups, an unpaired t-test or nonparametric
Mann-Whitney U-test was performed. For more than two groups, a
Kruskal-Wallis test was used. A P value 0.05 was considered
indicative of a significant difference.
RESULTS
Renal morphology and histopathological scoring. Ten days
of UUO resulted in a significant shrinkage of the obstructed
kidney (Table 1), as judged by the ratio of kidney weight to
body weight (KW/BW) compared with control nonobstructed
kidney (CK). RUUO resulted in a remarkable restoration of
kidney weight within 21 days, in accord with previous obser-
vations by Cochrane et al. (6).
Table 1. Kidney weight and renal cortical thickness after UUO and 3 wk after relief of UUO
Group n Treatment
Percent Kidney Weight, %body wt Cortical Thickness, mm
Contr Obstr Contr Obstr
1 4 Unilateral control 0.91	 0.02 1,244	 18
2 6 10-day UUO 1.02	 0.05 0.77 	 0.03* 1,344 	 95 900 	 45*
3 4 10-day UUO 
3-wk relief 0.86	 0.04 0.84 	 0.04 1,280 	 110 1,171 	 77
4 4 L-NMMA only 0.83	 0.07 1,217	 118
5 4 10-day UUO 
 L-NMMA 0.77	 0.07 0.74 	 0.03* 1,250 	 92 964 	 26*
6 4 10-day UUO 
3 wk 
 L-NMMA 0.71 	 0.02 0.71 	 0.01 1,312 	 38 1,166 	 48
7 4 AMD3100 only 0.80	 0.03 1,207	 49
8 6 10-day UUO 
 AMD3100 0.78	 0.04 0.70 	 0.02* 1,214 	 35 971 	 67*
9 4 10-day UUO 
3 wk 

AMD3100
1.16 	 0.01* 0.39 	 0.07* 1,407 	 37* 507 	 39*
Values are means 	 SE for n mice. UUO, unilateral ureteral obstruction; Contr, contralateral nonobstructed kidney; Obstr, UUO; L-NMMA, NG-monomethyl-
L-arginine. *P  0.05 compared with control kidney.
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Renal morphology and tubulointerstitial damage were ex-
amined with H & E staining and Masson’s trichrome or Sirius
red, respectively. The CK showed normal histoarchitecture,
with distinct cortex, medulla, and renal papilla. In contrast,
UUO kidney displayed conspicuous dilated proximal tubules
and increased collagen deposition in tubulointerstitial areas
(Fig. 1). UUO was associated with a marked attenuation of
renal papilla and thinning of outer medulla and cortex (25%
reduction from CK). However, after 3 wk of RUUO, the cortex
and the medulla showed a remarkable restoration of renal
parenchyma. Cortical thickness was recovered almost to con-
trol level (14% increased from UUO).
Stem cell accumulation during UUO. One of the possible
mechanisms to account for the rapid restoration of the renal
parenchyma after the relief of obstruction could be stem cell
dependent. To determine the possible participation of stem
cells during UUO or during regenerative processes after
RUUO, we performed flow cytometric analysis of cells iso-
lated from whole kidneys. Compared with CK, flow cytometric
analysis of renal cells isolated from UUO kidney demonstrated
a significant increase in CD34/Flk-1 (3-fold vs. control; ap-
proximate number of these cells in the kidney averages 3 104
in control and 9.9  104 in UUO) and CD150/c-kit (9-fold vs.
control; approximate number of these cells in the kidney
averages 21  104 in control and 134  104 in UUO)
double-positive cells, indicative of EPC and HSC accumula-
tion, respectively. Nestin (4-fold vs. control)- and vimentin
(15-fold vs. control)-positive cells, as well as CD29/CD44
(5-fold vs. control; approximate number of these cells in the
kidney averages 13  104 in control and 78  104 in UUO)
double-positive cells were also significantly increased after
UUO, suggesting an increase in cells of the mesenchymal
lineage during UUO. Ten-day UUO followed by 3 wk of
RUUO was characterized by a significant drop in EPC, HSC,
and MSC almost to baseline control levels (Figs. 2 and 3).
Effect of nitric oxide synthase inhibition on natural course of
UUO and its relief. There is accumulating, albeit controversial,
evidence linking stem cell mobilization with nitric oxide syn-
thase (NOS) function (1, 13). Therefore, we addressed the next
question: Does inhibition of NOS with nonhypertensinogenic
doses of L-NMMA affect stem cell recruitment by the ob-
structed kidney? To avoid any contribution of elevation in
blood pressure to the results of UUO, we employed subpressor
doses of L-NMMA that have been shown to induce a mild
endothelial dysfunction but no proteinuria or other functional
changes in the kidney (19). UUO kidneys from L-NMMA-
treated mice showed a similar reduction of KW/BW compared
with CK or RUUO kidney of nontreated mice. The data
demonstrated that L-NMMA-treated CK showed normal histo-
architecture except for a slight increase in perivascular fibrosis
and UUO kidneys displayed marked tubular dilatation with
increased interstitial collagen deposition. After 3 wk of RUUO,
L-NMMA-treated kidneys showed a significant restoration of
tubular dilatation and decline in interstitial collagen deposition
(Fig. 1, D–F).
Subpressor doses of L-NMMA (0.3 mg/ml) also showed a
similar pattern of increase in EPC, HSC, and MSC during
UUO. Such increase in EPC, HSC, and nestin- and vimentin-
positive cells during UUO was attenuated after RUUO, as in
the control group. Of interest, the increase in EPC was signif-
icantly less pronounced in the L-NMMA-treated mice com-
pared with the nontreated control group. On the other hand, the
CD150/c-kit-positive cells and nestin- and vimentin-positive
cells showed comparable increase after UUO in control and
L-NMMA-treated mice. These data indicate that subpressor
doses of L-NMMA, previously shown to be associated with
mild endothelial dysfunction (19), did not significantly alter the
course of UUO or RUUO, despite the curtailed surge in renal
EPC. Hence, it appears that mild nitric oxide deficiency does
not alter fibrotic and regenerative processes at least in the
present experimental setting (Fig. 3).
Blockade of stem cell recruitment to obstructed kidney and
its effect on postobstructive regeneration. To elucidate the role
accumulating stem cells during UUO play in post-RUUO
regeneration, we next attempted to prevent engraftment of
kidney by stem/progenitor cells. Blockade of CXCR4 receptor
by AMD3100 treatment significantly blunted the increase of
EPC, HSC, and MSC during UUO (group 2 vs. group 8),
suggesting possible attenuation of stem cell engraftment in
UUO kidney. Late increase in EPC, HSC, and MSC was noted
after discontinuation of AMD3100 treatment in RUUO kidney
(Fig. 4).
AMD3100-treated mice showed a significant reduction of
KW/BW in UUO kidneys compared with CK. Furthermore,
Fig. 1. Representative images of the kidneys obtained from mice with unilateral ureteral obstruction (UUO) and after its release (RUUO) A: control nonobstructed
kidney showing normal distinct cortex, medulla, and renal papilla without interstitial fibrosis. B: marked attenuation of renal papilla and outer medullary area
with thinning of renal cortex. Markedly dilated tubules and increased collagen deposition are seen with 10-day UUO. C: mild dilatation of tubules with partial
restoration of renal parenchyma are noted 3 wk after RUUO. D: NG-monomethyl-L-arginine (L-NMMA)-treated control mice show normal histoarchitecture
except for a minimal increase in perivascular fibrosis. E: UUO on the L-NMMA background demonstrates marked tubular dilatation with increased collagen
deposition. F: RUUO on the L-NMMA background displays significant restoration of histoarchitecture and reduced collagen deposition. Masson’s trichrome
stain: top, panoramic views at magnification 40; bottom, magnification 400. n  4–6 in each group.
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RUUO kidneys showed further decrease in KW/BW compared
with control kidneys (Table 1). CK in AMD3100-treated mice
showed a near normal histoarchitecture, whereas UUO kidney
showed a significant increase in tubular injury and interstitial
fibrosis that was accompanied by marked attenuation of renal
papilla with thinning of outer medulla and cortex (Table 2). In
contrast to nontreated control mice subjected to the analogous
treatments, 3 wk of RUUO in AMD3100-treated mice
showed further aggravation in the loss of renal parenchyma
with persisting papillary attenuation and renal pelvis dila-
tation (Fig. 5).
Role of caveolin-1 expression level in progression of fibrosis.
Another way to manipulate stem cell engraftment of the kidney
is through regulation of caveolin-1 expression. Caveolin-1
expression is a prerequisite for stem cell engraftment because
CXCR4 dimerization induced by stromal cell-derived factor-1
(SDF-1) occurs in caveolar lipid-rich domains (24). It has been
shown that incorporation of CXCR4 into membrane lipid rafts
is necessary for SDF-1-induced homing of HSC and EPC (25).
These data raised the question of the role played by CXCR4-
SDF-1 interaction in the observed surge of stem cells in the
obstructed kidney.
Fig. 2. Typical FACS gating parameters and
distribution of cells of interest (A) and bar dia-
grams summarizing the proportion of CD34
/
Flk-1
 [endothelial progenitor (EPC); B],
c-Kit
/CD150
 [hematopoietic stem (HSC);
C], and CD44
/CD29
 [mesenchymal stem
(MSC); D] cells. *P  0.05.
Fig. 3. Stem cell mobilization during UUO and
RUUO. Flow cytometric analysis of single-cell
suspensions prepared from kidneys of control,
UUO, and RUUO in naive and L-NMMA-treated
mice as described in MATERIALS AND METHODS.
Compared with control, UUO kidneys demon-
strated a significant increase in EPC (A), HSC
(B), and CML (C, D), and this surge in stem cells
decreased almost back to baseline 3 wk after
RUUO. UUO in mice treated with nonpressor
dose of L-NMMA also showed similar surge of
stem cells. However, the increase in EPC was
less pronounced compared with the control
group. Values are means	 SE; n 4–8 in each
group.
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To address this question, we examined the course of UUO in
caveolin-1-deficient and caveolin-1-overexpressing mice. Ge-
netic manipulation of caveolin-1 expression level resulted in
strikingly divergent responses to UUO. In caveolin-1/ mice,
the degree of developing fibrosis was dramatically increased
compared with wild-type and caveolin-1-overexpressing trans-
genic animals (Fig. 6). At the level of the microvasculature,
however, the highest increase in neointimal formation, as judged
by the media-to-lumen ratio, was detected in caveolin-1-overex-
pressing mice (Fig. 7).
The abundance of stem cells in the kidney was examined
next. As shown in Fig. 8, only the postobstructive surge of
MSC in the kidney was dramatically curtailed in caveolin-
1/ mice, whereas EPC and HSC, although slightly reduced,
did not change significantly. The fact that caveolin-1 defi-
ciency was associated with the worsening of interstitial fibrosis
and reduction in renal MSC, compared with obstruction in
wild-type mice, suggests that accumulation of MSC does not
necessarily lead to aggravation of fibrosis; rather it is the
reduction of their surge that is associated with worsening of
interstitial fibrosis.
DISCUSSION
UUO is associated with progressive renal fibrosis and scar-
ring and a decline in renal function. RUUO is characterized by
a variable recovery of renal function and structural repair of
renal parenchyma. Although numerous studies have examined
the events that lead to renal fibrosis, less is known about the
inherent mechanisms that promote tissue remodeling and re-
generation. A mouse model of UUO and RUUO that results in
the development of renal fibrosis and loss of parenchyma
followed by resolution of renal injury and regeneration of renal
parenchyma was established by Cochrane et al. (6) and reex-
amined here, along with several recently discovered modula-
tors of fibrosis and/or regeneration.
The obstructed kidney from 10-day UUO demonstrated
profound ablation of renal cortex and outer medulla and was
accompanied by marked increase in EPC, HSC, and MSC in
the renal parenchyma. After 3-wk RUUO, cortical parenchy-
mal thickness was nearly restored, along with decrease of EPC,
HSC, and vimentin- or nestin-positive cells. Treatment with
AMD3100, a specific antagonist of CXCR4, markedly attenu-
ated observed stem cell mobilization during 10-day UUO and
was associated with the failure to regenerate renal parenchyma
after 3-wk RUUO. Flow cytometric analysis of renal paren-
chymal cells in AMD3100-treated mice after 3-wk RUUO
showed delayed marked increase in EPC, HSC, and vimentin-
and nestin-positive, as well as CD29- and CD44-positive cells.
These results suggest that a wave of stem cell accumulation in
the kidney during the period of obstruction, but not after its
Fig. 4. Effect of AMD3100 on stem cell mobilization
in control, UUO, and RUUO kidneys. AMD3100
treatment significantly attenuated the increase of EPC
(A), HSC (B), and MSC (C) during UUO, suggesting
blunting of stem cell engraftment in the kidney. Late
increase in EPC, HSC, and CML was noted after
discontinuation of AMD3100 treatment in RUUO kid-
ney. Values are means	 SE; n 4–6 in each group.
*P  0.05 vs. UUO; **P  0.05 vs. control; #P 
0.05 vs. AMD3100-treated mice.
Table 2. Tubulointerstitial injury score
Group n TIS Tubular Injury Fibrosis Score Pelvis Dilatation Papillary Attenuation
1 4 0.01 0.01 0.01
2 6 3.90 	 0.87 2.34	 0.53 1.56	 0.34 2.89	 0.07 2.56	 0.17
3 4 0.31 	 0.22 0.01 0.31 	 0.22 0.50	 0.29 0.01
4 4 0.08 0.01 0.08
5 4 4.07 	 1.35 1.78	 0.49 2.29	 0.86 2.25	 0.31 2.19	 0.37
6 4 0.63 	 0.38 0.01 0.63 	 0.38 1.25	 0.25 1.25	 0.25
7 4 0.1 	 0.18 0.01 0.1 	 0.18
8 6 3.63 	 1.2 1.84	 0.62 1.79	 0.58 2.14	 0.49 2.13	 0.44
9 4 5.17 	 0.83 2.78	 0.35 2.39	 0.48 2.86	 0.24 2.71	 0.41
Values are means 	 SE for n mice. TIS, composite tubular injury score ( tubular injury 
 fibrosis score).
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release, may serve as a mechanism of renal structural repair
following RUUO.
Owing to the fact that all studied cells, EPC, HSC, and MSC,
showed a surge in the obstructed kidneys, it is difficult to
dissociate the contribution of each cell type to the postrelief
structural recovery. In this vein, the results of L-NMMA
pretreatment may shed some light. Under these experimental
conditions, only the surge in EPC was found to be inhibited,
whereas the numbers of HSC and MSC residing in the ob-
structed kidneys were not different from nontreated controls.
The fact that this did not affect the regenerative outcome after
the release of obstruction may be indicative of the leading role
played by HSC and/or MSC in the positive remodeling. It must
be acknowledged, however, that a two-parameter assignment
of cells to different stem cell populations is tenuous. Despite
the fact that traditional markers have been utilized in this study,
some overlap with nonstem cells is inevitable and interpreta-
tion of findings requires caution.
Prior experience with stem cell mobilization or transplanta-
tion in UUO brought about conflicting results. Stem cell factor
(SCF)- or granulocyte-colony stimulating factor (G-CSF)-in-
duced mobilization of bone marrow stem cells did not reduce
tubulointerstitial fibrosis in UUO (20). This finding may be
difficult to interpret as it could represent the net result of
opposing trends due to the multicellular nature of mobilizing
effects elicited by either of these agents, which could have
canceled each other. For instance, increased influx of classi-
cally activated macrophages could potentially aggravate fibro-
sis, in fact reversing any possible beneficial effect observed
upon macrophage depletion in UUO (21). In accord with our
findings, however, label-retaining cells were found in increased
numbers after UUO (26), where they reportedly participated in
epithelial-mesenchymal transition. The role played by these
cells in postrelief remodeling and tissue regeneration was not
studied. Our data suggest that the accumulated stem cells could
have participated in this process. This conclusion is based on
Fig. 5. Effect of AMD3100 on postobstructive kid-
ney regeneration: representative images of kidneys
obtained from mice with 10-day UUO and 3 wk
after its release. AMD3100-treated control mice kid-
ney appears grossly normal (A). UUO in AMD3100
treated mice demonstrated marked tubular dilatation
with increased collagen deposition. Moreover,
marked attenuation of renal papilla and thinning of
outer medullar and cortical areas are noted (B). After
3 wk of RUUO, AMD3100-treated kidneys display
further shrinkage of renal parenchyma, especially
the outer medulla and the cortex (C). Masson’s
trichrome stain: top, panoramic views at magnifica-
tion 40; bottom, magnification 400; n  4–6 in
each group.
Fig. 6. Fibrosis is prevalent in caveolin-1/ ob-
structed kidneys. Quantitative assessment of the degree
of fibrosis, as assessed with Sirius red (SR) staining, in
Cav-1/ and Cav-1-overexpressing mice compared
with wild-type (WT) counterparts subjected to UUO
(top) and representative images of obstructed kidneys
(bottom). Values are means 	 SE; n  4–6.
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the demonstration of halted and even reversed regeneration in
mice treated with AMD3100, which curtailed the accumulation
of stem cells in the kidney, possibly via the reduced engraft-
ment. Indeed, we have no data to support or reject the possi-
bility of engraftment versus proliferation of resident stem cells
in the obstructed kidney; such an analysis would require cell
fate tracing experiments. EPC did not appear to be of critical
importance for the regenerative processes, insofar as preven-
tion of their accumulation in the obstructed kidney did not
palpably affect the postrelief outcome.
It can be argued that the detectable population of CD34-
positive/Flk-1-positive cells may incorporate mature endothe-
lial cells. Unfortunately, this is an unavoidable limitation of the
techniques used. However, considering the opposite trends in
the shrinking size of population of vascular endothelial cells in
the obstructed kidney vis-à-vis the growing number of detect-
able CD34
/Flk-1
 cells, it is reasonable to assume that the
difference reflects the increased contribution by EPC.
The data obtained in caveolin-1 knockout and transgenic
mice may emphasize the contribution of enhanced stem cell
mobilization and impaired engraftment: Apart from its role in
the activation of CXCR4, caveolin-1 may also play an impor-
tant role in stem cell mobilization. Sbaa et al. (18) have
demonstrated that neovascularization in Cav-1/ mice im-
paired because of the defective mobilization of EPC from the
bone marrow after stimulation with SDF-1. This was due to the
blockade of CXCR4 internalization in the absence of caveo-
lin-1. At the same time, adhesion of Cav-1/ EPC to
SDF-1-presenting endothelial cells was enhanced, a property
that could be reproduced in wild-type mice by small interfering
RNA inhibition of caveolin-1 expression. These data empha-
size the existing caveolin-dependent dualism in SDF-1-induced
actions on CXCR4: Caveolin-1 deficiency causes both reduced
mobilization and enhanced homing, a paradox that requires
further in-depth studies. Using fluorescence resonance energy
transfer, Toth et al. (22) demonstrated that SDF-1 enhanced
CXCR4 receptor dimerization, an effect that was inhibited by
the CXCR4 antagonist AMD3100. In a model of vascular
injury, however, caveolin-1 deficiency enhances neointimal
formation (10). Caveolin-1 deficiency has been found to in-
crease cell proliferation and collagen synthesis, thus leading to
myocardial hypertrophy and pulmonary hypertension; both
were normalized in Cav-1/ mice by reexpressing caveo-
lin-1 in endothelial cells (14). In accord with this, administra-
tion of caveolin-1 scaffolding domain peptide (Cavtratin) af-
fords an antifibrotic effect in lung injury (23).
In addition, our data suggest that the timing of stem cell
accumulation in the renal parenchyma of the obstructed kidney
is of essence: Despite the fact that cells reaccumulate after the
relief of obstruction and cessation of AMD treatment, regen-
eration does not occur and fibrosis progresses.
In conclusion, the data presented here extend previous ob-
servations by Cochrane et al. (6), as well as the existing clinical
experience on the regenerative capacity of the kidney after
obstruction has been relieved. One of the proposed mecha-
nisms for positive kidney remodeling under these conditions
has been identified here as the accumulation of stem cells and
the derailment of parenchymal regeneration when the surge in
stem cells was halted. The data presented allow us to rule out
the major role of EPC in this process and suggest the potential
contribution of MSC and HSC, although they do not distin-
guish between them.
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